Epidemiology of dementia;Épidémiologie des démences

Presse Medicale

Volumn 36, Issue 10 II, 2007, Pages 1431-1441

  Berr, Claudine ^a   Akbaraly, Tasnime Nassime ^a   Nourashemi, Fati ^b   Andrieu, Sandrine ^b  

^a INSERM   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CANDESARTAN; INDAPAMIDE; PERINDOPRIL;

CLINICAL ASSESSMENT; DEMENTIA; DIABETES MELLITUS; DYSLIPIDEMIA; FEEDING BEHAVIOR; HABIT; HEALTH; HEALTH CARE; HUMAN; HYPERTENSION; INTELLIGENCE; INTERVENTION STUDY; LIFESTYLE; MORBIDITY; PHYSICAL ACTIVITY; PREVALENCE; PUBLIC HEALTH PROBLEM; RISK FACTOR; SHORT SURVEY; SOCIAL BEHAVIOR; SURVIVAL; AGE; AGED; ALZHEIMER DISEASE; COHORT ANALYSIS; COMPARATIVE STUDY; EDUCATION; EUROPE; FEMALE; INCIDENCE; MALE; MORTALITY; MULTIINFARCT DEMENTIA; NUTRITION; REVIEW; SEX DIFFERENCE; SOCIOECONOMICS; TIME;

AGE FACTORS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COHORT STUDIES; DEMENTIA; DEMENTIA, VASCULAR; EDUCATION; EUROPE; FEMALE; HUMANS; INCIDENCE; LIFE STYLE; MALE; NUTRITION PHYSIOLOGY; PREVALENCE; RISK FACTORS; SEX FACTORS; SOCIOECONOMIC FACTORS; TIME FACTORS;

EID: 34848888663     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2007.04.022     Document Type: Short Survey

References (107)

1. Kurz X., Scuvee-Moreau J., Salmon E., Pepin J.L., Ventura M., and Dresse A. La démence en Belgique : taux de prévalence chez les sujets âgés consultant en médecine générale. Rev Med Liege 56 (2001) 835-839
2. Tyas S.L., Tate R.B., Wooldrage K., Manfreda J., and Strain L.A. Estimating the incidence of dementia: the impact of adjusting for subject attrition using health care utilization data. Ann Epidemiol 16 (2006) 477-484
3. Letenneur L., Dequae L., Jacqmin H., Nuissier J., Decamps A., Barberger-Gateau P., et al. Prévalence de la démence en Gironde (France). Rev Epidemiol Sante Publique 41 (1993) 139-145
4. Ramaroson H., Helmer C., Barberger-Gateau P., Letenneur L., and Dartigues J.F. Prévalence de la démence et de la maladie d'Alzheimer chez les personnes de 75 ans et plus : données réactualisées de la cohorte Paquid. Rev Neurol (Paris) 159 (2003) 405-411
5. Lobo A., Launer L.J., Fratiglioni L., Andersen K., Di Carlo A., Breteler M.M., et al. Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 54 Suppl 5 (2000) S4-S9
6. Fitzpatrick A.L., Kuller L.H., Ives D.G., Lopez O.L., Jagust W., Breitner J.C., et al. Incidence and prevalence of dementia in the Cardiovascular Health Study. J Am Geriatr Soc 52 (2004) 195-204
7. De Ronchi D., Berardi D., Menchetti M., Ferrari G., Serretti A., Dalmonte E., et al. Occurrence of cognitive impairment and dementia after the age of 60: a population-based study from Northern Italy. Dement Geriatr Cogn Disord 19 (2005) 97-105
8. Knopman D.S., Petersen R.C., Cha R.H., Edland S.D., and Rocca W.A. Incidence and causes of nondegenerative nonvascular dementia: a population-based study. Arch Neurol 63 (2006) 218-221
9. Letenneur L., Dequae L., Jacqmin H., Nuissier J., Decamps A., Barberger-Gateau P., et al. Prévalence de la démence en Gironde (France). Rev Epidemiol Sante Publique 41 (1993) 139-145
10. Ramaroson H., Helmer C., Barberger-Gateau P., Letenneur L., and Dartigues J.F. Prévalence de la démence et de la maladie d'Alzheimer chez les personnes de 75 ans et plus: Données réactualisées de la cohorte PAQUID. Rev Neurol (Paris) 159 (2003) 405-411
11. Fratiglioni L., Launer L.J., Andersen K., Breteler M.M., Copeland J.R., Dartigues J.F., et al. Incidence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurology 54 (2000) S10-S15
12. Berr C., Wancata J., and Ritchie K. Prevalence of dementia in the elderly in Europe. Eur Neuropsychopharmacol 15 (2005) 463-471
13. Rahkonen T., Eloniemi-Sulkava U., Rissanen S., Vatanen A., Viramo P., and Sulkava R. Dementia with Lewy bodies according to the consensus criteria in a general population aged 75 years or older. J Neurol Neurosurg Psychiatry 74 (2003) 720-724
14. Von Strauss E., Viitanen M., DeRonchi D., Winblad B., and Fratiglioni L. Aging and the occurrence of dementia - Findings from a population- based cohort with a large sample of nonagenarians. Arch Neurol 56 (1999) 587-592
15. Ankri J., and Poupard M. Prévalence et incidence des démences au grand âge analyse de la littérature. Rev Epidemiol Sante Publique 51 (2003) 349-360
16. Rocca W.A., Cha R.H., Waring S.C., and Kokmen E. Incidence of dementia and Alzheimer's disease: a reanalysis of data from Rochester, Minnesota, 1975-1984. Am J Epidemiol 148 (1998) 51-62
17. Helmer C., Pasquier F., and Dartigues J.F.E. Épidémiologie de la maladie d'Alzheimer et des syndromes apparentés. Med Sci (Paris) 22 (2006) 288-296
18. Ferri C.P., Prince M., Brayne C., Brodaty H., Fratiglioni L., Ganguli M., et al. Global prevalence of dementia: a Delphi consensus study. Lancet 366 (2005) 2112-2117
19. Wimo A., Winblad B., Aguero-Torres H., and von Strauss E. The magnitude of dementia occurrence in the world. Alzheimer Dis Assoc Disord 17 (2003) 63-67
20. Brookmeyer R., Gray S., and Kawas C. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health 88 (1998) 1337-1342
21. Brookmeyer R., and Gray S. Methods for projecting the incidence and prevalence of chronic diseases in ageing populations: application to Alzheimer's disease. Stat Med 19 (2000) 1481-1493
22. Wolfson C., Wolfson D.B., Asgharian M., M'Lan C.E., Ostbye T., Rockwood K., et al. A reevaluation of the duration of survival after the onset of dementia. N Engl J Med 344 (2001) 1111-1116
23. Helmer C., Joly P., Letenneur L., Commenges D., and Dartigues J.F. Mortality with dementia: Results from a French prospective community-based cohort. Am J Epidemiol 154 (2001) 642-648
24. Jagger C., Andersen K., Breteler M.M., Copeland J.R., Helmer C., Baldereschi M., et al. Prognosis with dementia in Europe: A collaborative study of population-based cohorts. Neurology 54 (2000) S16-S20
25. Yaffe K., Fox P., Newcomer R., Sands L., Lindquist K., Dane K., et al. Patient and caregiver characteristics and nursing home placement in patients with dementia. JAMA 287 (2002) 2090-2097
26. Severson M.A., Smith G.E., Tangalos E.G., Petersen R.C., Kokmen E., Ivnik R.J., et al. Patterns and predictors of institutionalization in community-based dementia patients. J Am Geriatr Soc 42 (1994) 181-185
27. Knopman D., Kitto J., Deinard S., and Heiring J. Longitudinal study of death and institutionnalization in patients with primary degenerative dementia. J Am Geriatr Soc 36 (1988) 108-112
28. Fratiglioni L., Paillard Borg S., and Winblad B. An active and socially integrated lifestyle in late life might protect against dementia. Lancet Neurol 3 (2004) 343-353
29. Whalley L.J., Dick F.D., and McNeill G. A life-course approach to the aetiology of late-onset dementias. Lancet Neurol 5 (2006) 87-96
30. Launer L.J., Andersen K., Dewey M.E., Letenneur L., Ott A., Amaducci L.A., et al. Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia. Neurology 52 (1999) 78-84
31. Gao S., Hendrie H.C., Hall K.S., and Hui S. The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis. Arch Gen Psychiatry 55 (1998) 809-815
32. Letenneur L., Gilleron V., Commenges D., Helmer C., Orgogozo J.M., and Dartigues J.F. Are sex and educational level independent predictors of dementia and Alzheimer's disease? Incidence data from the PAQUID project. J Neurol Neurosurg Psychiatry 66 (1999) 177-183
33. Letenneur L., Launer L.J., Andersen K., Dewey M.E., Ott A., Copeland J.R., et al. Education and the risk for Alzheimer's disease: sex makes a difference. EURODEM pooled analyses. EURODEM Incidence Research Group. Am J Epidemiol 151 (2000) 1064-1071
34. Richards M., Shipley B., Fuhrer R., and Wadsworth M.E. Cognitive ability in childhood and cognitive decline in mid-life: longitudinal birth cohort study. BMJ 328 (2004) 552
35. Evans D.A., Hebert L.E., Beckett L.A., Scherr P.A., Albert M.S., Chown M.J., et al. Education and other measures of socioeconomic status and risk of incident Alzheimer disease in a defined population of older persons. Arch Neurol 54 (1997) 1399-1405
36. Wilson R.S., Scherr P.A., Hoganson G., Bienias J.L., Evans D.A., and Bennett D.A. Early life socioeconomic status and late life risk of Alzheimer's disease. Neuroepidemiology 25 (2005) 8-14 (Epu)
37. Wilson R.S., Mendes De Leon C.F., Barnes L.L., Schneider J.A., Bienias J.L., Evans D.A., et al. Participation in cognitively stimulating activities and risk of incident Alzheimer disease. JAMA 287 (2002) 742-748
38. Larson E.B., Wang L.I., Bowen J., Mccormick W.C., Teri L., Crane P., et al. Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older. Ann Intern Med 144 (2006) 73-81
39. Abbott R.D., White L.R., Ross G.W., Masaki K.H., Curb J.D., and Petrovitch H. Walking and dementia in physically capable elderly men. JAMA 292 (2004) 1447-1453
40. Teri L., Gibbons L.E., McCurry S.M., Logsdon R.G., Buchner D.M., Barlow W.E., et al. Exercise plus behavioral management in patients with Alzheimer disease: a randomized controlled trial. JAMA 290 (2003) 2015-2022
41. Juan D., Zhou D.H., Li J., Wang J.Y., Gao C., and Chen M. A 2-year follow-up study of cigarette smoking and risk of dementia. Eur J Neurol 11 (2004) 277-282
42. Lemeshow S., Letenneur L., Dartigues J.F., Lafont S., Orgogozo J.M., and Commenges D. Illustration of analysis taking into account complex survey considerations: the association between wine consumption and dementia in the PAQUID study. Personnes Ages Quid. Am J Epidemiol 148 (1998) 298-306
43. Letenneur L., Larrieu S., and Barberger-gateau P. Alcohol and tobacco consumption as risk factors of dementia: a review of epidemiological studies. Biomed Pharmacother 58 (2004) 95-99
44. Petrovitch H., White L.R., Izmirilian G., Ross G.W., Havlik R.J., Markesbery W., et al. Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS. Neurobiol Aging 21 (2000) 57-62
45. Tzourio C., Dufouil C., Ducimetiere P., and Alperovitch A. Cognitive decline in individuals with high blood pressure: a longitudinal study in the elderly. EVA Study Group. Epidemiology of Vascular Aging. Neurology 53 (1999) 1948-1952
46. Qiu C., Winblad B., and Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 4 (2005) 487-499
47. Forette F., Seux M.L., Staessen J.A., Thijs L., Birkenhager W.H., Babarskiene M.R., et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 352 (1998) 1347-1351
48. Tzourio C., Anderson C., Chapman N., Woodward M., Neal B., Macmahon S., et al. Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 163 (2003) 1069-1075
49. Lithell H., Hansson L., Skoog I., Elmfeldt D., Hofman A., Olofsson B., et al. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens 21 (2003) 875-886
50. Sambamurti K., Granholm A.C., Kindy M.S., Bhat N.R., Greig N.H., Lahiri D.K., et al. Cholesterol and Alzheimer's disease: clinical and experimental models suggest interactions of different genetic, dietary and environmental risk factors. Curr Drug Targets 5 (2004) 517-528
51. Shobab L.A., Hsiung G.Y., and Feldman H.H. Cholesterol in Alzheimer's disease. Lancet Neurol 4 (2005) 841-852
52. Zandi P.P., Sparks D.L., Khachaturian A.S., Tschanz J., Norton M., Steinberg M., et al. Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study. Arch Gen Psychiatry 62 (2005) 217-224
53. Rea T.D., Breitner J.C., Psaty B.M., Fitzpatrick A.L., Lopez O.L., Newman A.B., et al. Statin use and the risk of incident dementia: the Cardiovascular Health Study. Arch Neurol 62 (2005) 1047-1051
54. Li G., Higdon R., Kukull W.A., Peskind E., Van Valen Moore K., Tsuang D., et al. Statin therapy and risk of dementia in the elderly: a community-based prospective cohort study. Neurology 63 (2004) 1624-1628
55. Shepherd J., Blauw G.J., Murphy M.B., Bollen E.L., Buckley B.M., Cobbe S.M., et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 360 (2002) 1623-1630
56. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360 (2002) 7-22
57. Sparks D.L., Sabbagh M.N., Connor D.J., Lopez J., Launer L.J., Browne P., et al. Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results. Arch Neurol 62 (2005) 753-757
58. Biessels G.J., Staekenborg S., Brunner E., Brayne C., and Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 5 (2006) 64-74
59. den Heijer T., Vermeer S.E., van Dijk E.J., Prins N.D., Koudstaal P.J., Hofman A., et al. Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI. Diabetologia 46 (2003) 1604-1610
60. Wu J.H., Haan M.N., Liang J., Ghosh D., Gonzalez H.M., and Herman W.H. Impact of antidiabetic medications on physical and cognitive functioning of older Mexican Americans with diabetes mellitus: a population-based cohort study. Ann Epidemiol 13 (2003) 369-376
61. Honig L.S., Tang M.X., Albert S., Costa R., Luchsinger J., Manly J., et al. Stroke and the risk of Alzheimer disease. Arch Neurol 60 (2003) 1707-1712
62. Luchsinger J.A., and Mayeux R. Cardiovascular risk factors and Alzheimer's disease. Curr Atheroscler Rep 6 (2004) 261-266
63. Helmer C., Peuchant E., Letenneur L., Bourdel-marchasson I., Larrieu S., Dartigues J.F., et al. Association between antioxidant nutritional indicators and the incidence of dementia: results from the PAQUID prospective cohort study. Eur J Clin Nutr 57 (2003) 1555-1561
64. Commenges D., Scotet V., Renaud S., Jacqmin-Gadda H., Barberger-Gateau P., and Dartigues J.F. Intake of flavonoids and risk of dementia. Eur J Epidemiol 16 (2000) 357-363
65. Berr C., Balansard B., Arnaud J., Roussel A.M., and Alperovitch A. Cognitive decline is associated with systemic oxidative stress: the EVA study. Etude du Vieillissement Arteriel. J Am Geriatr Soc 48 (2000) 1285-1291
66. Berr C., Richard M.J., Gourlet V., Garrel C., and Favier A. Enzymatic antioxidant balance and cognitive decline in aging--the EVA study. Eur J Epidemiol 19 (2004) 133-138
67. Engelhart M.J., Geerlings M.I., Ruitenberg A., Van Swieten J.C., Hofman A., Witteman J.C., et al. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 287 (2002) 3223-3229
68. Morris M.C., Evans D.A., Bienias J.L., Tangney C.C., Bennett D.A., Aggarwal N., et al. Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. JAMA 287 (2002) 3230-3237
69. Quadri P., Fragiacomo C., Pezzati R., Zanda E., Tettamanti M., and Lucca U. Homocysteine and B vitamins in mild cognitive impairment and dementia. Clin Chem Lab Med 43 (2005) 1096-1100
70. Ravaglia G., Forti P., Maioli F., Martelli M., Servadei L., Brunetti N., et al. Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am J Clin Nutr 82 (2005) 636-643
71. Kado D.M., Karlamangla A.S., Huang M.H., Troen A., Rowe J.W., Selhub J., et al. Homocysteine versus the vitamins folate, B6, and B12 as predictors of cognitive function and decline in older high-functioning adults: MacArthur Studies of Successful Aging. Am J Med 118 (2005) 161-167
72. Tucker K.L., Qiao N., Scott T., Rosenberg I., and Spiro III A. High homocysteine and low B vitamins predict cognitive decline in aging men: the Veterans Affairs Normative Aging Study. Am J Clin Nutr 82 (2005) 627-635
73. Garcia A., and Zanibbi K. Homocysteine and cognitive function in elderly people. CMAJ 171 (2004) 897-904
74. Stott D.J., MacIntosh G., Lowe G.D., Rumley A., McMahon A.D., Langhorne P., et al. Randomized controlled trial of homocysteine-lowering vitamin treatment in elderly patients with vascular disease. Am J Clin Nutr 82 (2005) 1320-1326
75. Kalmijn S., Feskens E.J., Launer L.J., and Kromhout D. Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men. Am J Epidemiol 145 (1997) 33-41
76. Engelhart M.J., Geerlings M.I., Ruitenberg A., Van Swieten J.C., Hofman A., Witteman J.C., et al. Diet and risk of dementia: Does fat matter? The Rotterdam Study. Neurology 59 (2002) 1915-1921
77. Barberger-Gateau P., Letenneur L., Deschamps V., Peres K., Dartigues J.F., and Renaud S. Fish, meat, and risk of dementia: cohort study. BMJ 325 (2002) 932-933
78. Morris M.C., Evans D.A., Bienias J.L., Tangney C.C., Bennett D.A., Wilson R.S., et al. Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Arch Neurol 60 (2003) 940-946
79. Morris M.C., Evans D.A., Tangney C.C., Bienias J.L., and Wilson R.S. Fish Consumption and Cognitive Decline With Age in a Large Community Study. Arch Neurol 62 (2005) 1849-1853
80. Heude B., Ducimetiere P., and Berr C. Cognitive decline and fatty acid composition of erythrocyte membranes. The EVA Study. Am J Clin Nutr 77 (2003) 803-808
81. Scarmeas N., Stern Y., Tang M.X., Mayeux R., and Luchsinger J.A. Mediterranean diet and risk for Alzheimer's disease. Ann Neurol 59 (2006) 912-921
82. Sobel E., Davanipour Z., Sulkava R., Erkinjuntti T., Wikstrom J., Henderson V.W., et al. Occupations with exposure to magnetic fields: a possible risk factor for Alzheimer's disease. Am J Epidemiol 142 (1995) 515-524
83. Feychting M., Pedersen N.L., Svedberg P., Floderus B., and Gatz M. Dementia and occupational exposure to magnetic fields. Scand J Work Environ Health 24 (1998) 46-53
84. Savitz D.A., Loomis D.P., and Tse C.K. Electrical occupations and neurodegenerative disease: analysis of U.S. mortality data. Arch Environ Health 53 (1998) 71-74
85. Hakansson N., Gustavsson P., Johansen C., and Floderus B. Neurodegenerative diseases in welders and other workers exposed to high levels of magnetic fields. Epidemiology 14 (2003) 420-426 (discussion 427-8)
86. Feychting M., Jonsson F., Pedersen N.L., and Ahlbom A. Occupational magnetic field exposure and neurodegenerative disease. Epidemiology 14 (2003) 413-419 (discussion 427-8)
87. Kukull W.A., Larson E.B., Bowen J.D., McCormick W.C., Teri L., Pfanschmidt M.L., et al. Solvent exposure as a risk factor for Alzheimer's disease: a case-control study. Am J Epidemiol 141 (1995) 1059-1071 (discussion 1072-9)
88. Nilson L.N., Sallsten G., Hagberg S., Backman L., and Barregard L. Influence of solvent exposure and aging on cognitive functioning: an 18 year follow up of formerly exposed floor layers and their controls. Occup Environ Med 59 (2002) 49-57
89. Bosma H., vanBoxtel M.P., Ponds R.W., Houx P.J., and Jolles J. Pesticide exposure and risk of mild cognitive dysfunction. Lancet 356 (2000) 912-913
90. Baldi I., Lebailly P., Mohammed-Brahim B., Letenneur L., Dartigues J.F., and Brochard P. Neurodegenerative diseases and exposure to pesticides in the elderly. Am J Epidemiol 157 (2003) 409-414
91. Gun R.T., Korten A.E., Jorm A.F., Henderson A.S., Broe G.A., Creasey H., et al. Occupational risk factors for Alzheimer disease: A case-control study. Alzheimer Dis Assoc Disord 11 (1997) 21-27
92. Gauthier E., Fortier I., Courchesne F., Pepin P., Mortimer J., and Gauvreau D. Environmental pesticide exposure as a risk factor for Alzheimer's disease: a case-control study. Environ Res 86 (2001) 37-45
93. Nordberg M., Winblad B., Fratiglioni L., and Basun H. Lead concentrations in elderly urban people related to blood pressure and mental performance: results from a population-based study. Am J Ind Med 38 (2000) 290-294
94. Letz R., Gerr F., Cragle D., Green R.C., Watkins J., and Fidler A.T. Residual neurologic deficits 30 years after occupational exposure to elemental mercury. Neurotoxicology 21 (2000) 459-474
95. Salib E., and Hillier V. A case-control study of Alzheimer's disease and aluminium occupation. Br J Psychiatry 168 (1996) 244-249
96. Graves A.B., Rosner D., Echeverria D., Mortimer J.A., and Larson E.B. Occupational exposures to solvents and aluminium and estimated risk of Alzheimer's disease. Occup Environ Med 55 (1998) 627-633
97. Rondeau V. A review of epidemiologic studies on aluminum and silica in relation to Alzheimer's disease and associated disorders. Rev Environ Health 17 (2002) 107-121
98. Rondeau V., Commenges D., Jacqmin-Gadda H., and Dartigues J.F. Relation between aluminum concentrations in drinking water and Alzheimer's disease: an 8-year follow-up study. Am J Epidemiol 152 (2000) 59-66
99. Mutter J., Naumann J., Sadaghiani C., Schneider R., and Walach H. Alzheimer disease: mercury as pathogenetic factor and apolipoprotein E as a moderator. Neuroendocrinol Lett 25 (2004) 331-339
100. Lund J.P., Mojon P., Pho M., and Feine J.S. Alzheimer's disease and edentulism. Age Ageing 32 (2003) 228-229
101. Ancelin M.L., and Berr C. Traitement hormonal de la ménopause et maladie d'Alzheimer. A l'ouest, rien de nouveau ?. Psychol Neuropsychiatr Vieil 1 (2003) 251-257
102. Ancelin M.L., and Ritchie K. Lifelong endocrine fluctuations and related cognitive disorders. Curr Pharm Des 11 (2005) 4229-4252
103. Hogervorst E., Williams J., Budge M., Riedel W., and Jolles J. The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: A meta- analysis. Neuroscience 101 (2000) 485-512
104. Leblanc A. Estrogen and Alzheimer's disease. Curr Opin Investig Drugs 3 (2002) 768-773
105. Shumaker S.A., Legault C., Kuller L., Rapp S.R., Thal L., Lane D.S., et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 291 (2004) 2947-2958
106. Shumaker S.A., Legault C., Rapp S.R., Thal L., Wallace R.B., Ockene J.K., et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 289 (2003) 2651-2662
107. Resnick S.M., Maki P.M., Rapp S.R., Espeland M.A., Brunner R., Coker L.H., et al. Effects of Combination Estrogen Plus Progestin Hormone Treatment on Cognition and Affect. J Clin Endocrinol Metab 91 (2006) 1802-1810